WOODBRIDGE, Conn. and
WARSAW, Poland, Oct. 17, 2017 /PRNewswire/ -- PlumCare, a DNA
advisory service for families, today announced a partnership with
PBKM FamiCord, the European leader in cord blood stem cell
banking. The new collaboration will deliver the first-ever
lifetime DNA testing and advisory services to help families take
control of their health. The service is called PlumCare DNA Advisor
- it provides families one place for DNA testing, genetic advisory
services and the ongoing monitoring of scientific advances relevant
to them.
"PlumCare DNA Advisor is like having a friend who's an expert
and monitors the latest advances in our understanding of the human
genome. The DNA Advisor has a full image of your DNA and reaches
out to you every time there's a new breakthrough that could impact
your health, explaining it in easy to understand terms. They help
guide you and your healthcare provider when needed to manage your
family's health with insights in a way never before possible," said Petros Tsipouras, Co-Founder and CEO of
PlumCare.
PlumCare combines the simplicity of a saliva-based DNA test,
whole exome sequencing (the standard for a more complete image of a
person's DNA), data from close family members (important to data
interpretation), family medical history, external research, ongoing
monitoring of scientific advances and analysis. The resulting
insights and advice help families to manage their well-being across
generations.
"We've heard from our customers that they are interested in DNA
testing services," said Jakub Baran
CEO of PBKM FamiCord. "Earlier DNA testing offers have been
interesting, but only provide a snapshot of human DNA understanding
at that moment in time. They did not consider the needs of new
families. We've been looking for a way to more fully deliver on the
promise of genetic insights and do it in a way that caters to the
families over the course of their lives."
Initial children's reports provide insights about hearing,
cardiac, connective tissue, metabolic, seizures, cancers and
response to anesthesia. Adults will also receive information
focused on cardiac, connective tissue, cancer and response to
medications and anesthesia.
Sending DNA samples is only the beginning of a lifelong
relationship. With a PlumCare DNA Advisor subscription, all
participating family members can look forward to valuable annual
reports and notifications. When new discoveries are made, each
individual can take full advantage of what evolving knowledge and
technology can mean to them. When appropriate, PlumCare DNA Advisor
will provide genetic counseling and referrals to local specialists
who can translate these insights into better life choices.
About PlumCare
PlumCare was created for families by two eminent clinical
geneticists, Dr. Paul Billings and
Dr. Petros Tsipouras. PlumCare DNA
Advisor provides access to the progress in genetics through DNA
testing, analysis, insights, and learnings from world-class
research. The service combines the simplicity of saliva-based whole
exome DNA testing, data from all participating family members
(family trios or more), family medical history, external research
and analysis. With a subscription, the service provides ongoing
monitoring of scientific advances with annual reports and
notifications. The insights, advice and access to local specialists
help families to manage unexpected or chronic illnesses and their
well-being across generations for a lifetime. Learn more at
www.plumcarehealth.com.
About PBKM FamiCord
Polski Bank Komórek Macierzystych (PBKM, Polish Stem Cell Bank)
leads FamiCord Group which is international group of cord blood
banks. FamiCord is by far the European leader in newly banked cord
blood units and currently stores more than 150,000 cord blood
units. The main area of PBKM business is family cord blood banking,
which gives the access to stem cell treatment when it is needed in
the family. FamiCord operates in Poland, Spain, Turkey, Hungary, Romania, Italy, and Latvia. In most of these markets the Group is
the market leader. Company services are also available in
Sweden, United Kingdom, Ukraine and Serbia. Additionally PBKM invests
in manufacturing and development of Advanced Therapy Medicinal
Products (ATMP) which are one of the most promising area of new
therapies in medicine. Since 2016 PBKM is listed on Warsaw Stock
Exchange.
View original content with
multimedia:http://www.prnewswire.com/news-releases/plumcare-partners-with-pbkm-famicord-to-bring-family-dna-testing-to-europe-300537406.html
SOURCE PlumCare